Market News
Thursday, September 22, 2016
BRIEF-CTi biopharma granted 180 day extension by NASDAQ to regain compliance
* CTi Biopharma granted 180 day extension by NASDAQ to
regain compliance with minimum bid price rule
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment